Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAscendis Pharma A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 6 | -$1.86 | -$1.24 | -$1.53 |
| Q2 2025 | 3 | -$1.53 | -$1.10 | -$1.29 |
| Q3 2025 | 3 | -$0.84 | -$0.61 | -$0.71 |
| Q4 2025 | 3 | -$0.40 | -$0.29 | -$0.34 |
| Q1 2026 | 4 | -$0.63 | -$0.45 | -$0.54 |
| Q2 2026 | 3 | -$1.05 | -$0.76 | -$0.89 |
| Q3 2026 | 3 | $1.89 | $2.63 | $2.23 |
| Q4 2026 | 4 | $2.58 | $3.58 | $3.04 |
Ascendis Pharma A/S Earnings Date And Information
Ascendis Pharma A/S last posted its earnings results on Wednesday, February 12th, 2025. The company reported $-0.68 earnings per share for the quarter, topping analysts' consensus estimates of $-1.2 by $0.52. The company had revenue of 173.92 M for the quarter and had revenue of 363.64 M for the year. Ascendis Pharma A/S has generated $-7 earnings per share over the last year ($-6.59 diluted earnings per share) and currently has a price-to-earnings ratio of -20.94. Ascendis Pharma A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based on prior year's report dates.
Ascendis Pharma A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/12/2025 | Q4 2024 | -$1.20 | -$0.67 | 0.53 | $119.66 M | $173.92 M |
| 09/30/2024 | Q3 2024 | N/A | $0.00 | N/A | $71.39 M | $57.83 M |
| 05/02/2024 | Q2 2024 | -$1.57 | -$1.91 | -0.34 | $82.80 M | $36.00 M |
| 02/07/2024 | Q1 2024 | -$2.15 | -$2.30 | -0.15 | $79.81 M | $95.89 M |
| 02/07/2024 | Q4 2023 | -$2.15 | -$1.53 | 0.62 | $93.73 M | $137.70 M |
| 09/29/2023 | Q3 2023 | N/A | -$2.88 | N/A | $49.05 M | $48.03 M |
| 04/27/2023 | Q2 2023 | -$2.84 | -$2.16 | 0.68 | $37.24 M | $47.39 M |
| 04/27/2023 | Q1 2023 | -$2.84 | -$1.98 | 0.86 | $21.50 M | $33.59 M |
| 02/16/2023 | Q4 2022 | -$2.50 | -$3.70 | -1.2 | N/A | $22.90 M |
| 08/10/2022 | Q3 2022 | -$2.11 | -$3.03 | -0.92 | $8.81 M | $15.29 M |
| 05/11/2022 | Q2 2022 | -$2.25 | -$1.46 | 0.79 | $5.60 M | $6.16 M |
| 05/11/2022 | Q1 2022 | -$2.25 | -$2.21 | 0.04 | N/A | $6.83 M |
| 03/02/2022 | Q4 2021 | -$2.57 | -$1.97 | 0.6 | N/A | $4.90 M |
| 11/10/2021 | Q3 2021 | -$2.60 | -$1.47 | 1.13 | $1.14 M | $1.11 M |
| 08/26/2021 | Q2 2021 | N/A | -$2.50 | N/A | $746,426 | $1.02 M |
| 08/26/2021 | Q1 2021 | N/A | -$1.17 | N/A | N/A | $746,000 |
| 11/12/2020 | Q4 2020 | N/A | -$2.60 | N/A | N/A | $535,000 |
| 11/12/2020 | Q3 2020 | N/A | -$2.31 | N/A | $1.39 M | $2.76 M |
| 05/19/2020 | Q2 2020 | -$1.43 | -$1.97 | -0.54 | $2.18 M | $1.44 M |
| 05/19/2020 | Q1 2020 | -$1.43 | -$1.32 | 0.11 | N/A | $2.23 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ascendis Pharma A/S Earnings: FAQ's
Ascendis Pharma A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based offlast year's report dates.
In the previous quarter, Ascendis Pharma A/S (:ASND) reported $-0.68 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.2 by $0.52.
The conference call for Ascendis Pharma A/S's latest earnings report can be listened to online.
The conference call transcript for Ascendis Pharma A/S's latest earnings report can be read online.
Ascendis Pharma A/S (:ASND) has a recorded annual revenue of $363.64 M.
Ascendis Pharma A/S (:ASND) has a recorded net income of $-378,084,000.Ascendis Pharma A/S has generated $-6.59 earnings per share over the last four quarters.
Ascendis Pharma A/S (:ASND) has a price-to-earnings ratio of -20.94 and price/earnings-to-growth ratio is -1.4.